1. Home
  2. Investing
  3. Stocks
  4. USA
  6. Ultragenyx Pharmaceutical Inc (RARE)
  7. Quote


Ultragenyx Pharmaceutical Stock Price

0.81 (1.02%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 476,482
Bid Price 75.08
Ask Price 84.41
News (1)
Day High 81.65


52 Week Range


Day Low 79.00
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Ultragenyx Pharmaceutical Inc RARE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.81 1.02% 80.50 18:00:04
Open Price Low Price High Price Close Price Prev Close
80.65 79.00 81.65 80.50 79.69
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,994 476,482 $ 80.78 $ 38,491,511 - 75.83 - 179.647
Last Trade Time Type Quantity Stock Price Currency
16:05:20 average 187 $ 80.50 USD


Draw Mode:

Ultragenyx Pharmaceutical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.46B 67.84M 41.02M $ 271.03M $ -265.04M -3.11 -14.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.56k 2.00%

more financials information »

Ultragenyx Pharmaceutical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RARE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week78.1581.6575.8378.04473,0652.353.01%
1 Month87.4991.1075.8382.12404,260-6.99-7.99%
3 Months80.665104.3875.8389.10419,962-0.165-0.2%
6 Months110.63119.5475.8394.17513,746-30.13-27.23%
1 Year92.26179.64775.83111.02498,623-11.76-12.75%
3 Years51.14179.64731.9975.57503,60529.3657.41%
5 Years62.82179.64731.9971.30491,74117.6828.14%

Ultragenyx Pharmaceutical Description

Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.